Abstract
S847 Efficacy of Guselkumab in Patients With Moderately to Severely Active Crohn’s Disease Not in Clinical Response at Week 12: Results From the GALAXI 1 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have